Cargando…
Regulation of Filaggrin, Loricrin, and Involucrin by IL-4, IL-13, IL-17A, IL-22, AHR, and NRF2: Pathogenic Implications in Atopic Dermatitis
Atopic dermatitis (AD) is an eczematous, pruritic skin disorder with extensive barrier dysfunction and elevated interleukin (IL)-4 and IL-13 signatures. The barrier dysfunction correlates with the downregulation of barrier-related molecules such as filaggrin (FLG), loricrin (LOR), and involucrin (IV...
Autor principal: | Furue, Masutaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432778/ https://www.ncbi.nlm.nih.gov/pubmed/32751111 http://dx.doi.org/10.3390/ijms21155382 |
Ejemplares similares
-
The Expression of Involucrin, Loricrin, and Filaggrin in Cultured Sebocytes
por: Lee, Weon Ju, et al.
Publicado: (2014) -
Regulation of Skin Barrier Function via Competition between AHR Axis versus IL-13/IL-4‒JAK‒STAT6/STAT3 Axis: Pathogenic and Therapeutic Implications in Atopic Dermatitis
por: Furue, Masutaka
Publicado: (2020) -
P38/ERK MAPK signaling pathways are involved in the regulation of filaggrin and involucrin by IL-17
por: Tan, Qi, et al.
Publicado: (2017) -
Antioxidant Artemisia princeps Extract Enhances the Expression of Filaggrin and Loricrin via the AHR/OVOL1 Pathway
por: Hirano, Akiko, et al.
Publicado: (2017) -
IL-4 Augments IL-31/IL-31 Receptor Alpha Interaction Leading to Enhanced Ccl 17 and Ccl 22 Production in Dendritic Cells: Implications for Atopic Dermatitis
por: Miake, Sho, et al.
Publicado: (2019)